ABSTRACT: A library of positional isomers of D-glucose (O-1−O-6) as ligands and their 11 light-active ruthenium conjugates has been synthesized. A protecting group strategy without the necessity of using palladium on carbon for the modification for the 2-O and 4-O position allows for the incorporation of sulfur donor atoms as ligands for transition metal complexes.
■ INTRODUCTION
Carbohydrates are a class of biomolecules ubiquitously present in nature, comprising monosaccharides, oligosaccharides, and polysaccharides, of which monosaccharides cannot be hydrolyzed further into smaller units. These molecules are recognized as important building blocks in the cell wall of bacteria, 1 ,2 in plants, 3 in the exoskeleton of insects, 4 in cell recognition processes, 5 and in the backbone of RNA and DNA 6 and are associated with many different physiological and disease-related processes. 7, 8 Among them, D-glucose is the most well-known monosaccharide as it serves as the primary source of chemical energy in eukaryotic cells for the production of ATP. 9 Otto Warburg found that cancer cells have an increased glycolysis rate for the production of ATP compared to normal cells. 10 As a consequence, glucose transporters (GLUTs) 1 and 3 are overexpressed in cancer cells. 11 In recent years, there has been a growing interest in using this effect to selectively deliver molecules of interest to cancer cells. In the field of diagnostic imaging, the well-known radiotracer 2-deoxy-2- [ 18 F]-fluoroglucose (2-FDG) selectively accumulates in cancer cells since its metabolic breakdown is hampered by the replacement of a hydroxyl group on the 2-position of D-glucose by fluoride. 12 This clinically approved agent allows PET imaging of tumors anywhere in the whole body. In the field of medicinal chemistry, glufosfamide has shown some success as a safer alternative for ifosfamide, an alkylating agent used in cancer treatment. The therapeutic efficiency of glufosfamide is thought to be higher due to its increased water solubility and preferred uptake in malignant cells versus normal cells. 13 Recently, Palay et al. have demonstrated that a series of glucose conjugates of platinum-based medicines are taken up via GLUT1.
14, 15 This result is in contrast to the observation of Schubiger, who found that none of their radiodiagnostic glycoconjugates based on 99m Tc were taken up via glucose transporters. 16 For ruthenium(II) polypyridyl-based drugs, this effect has not been thoroughly investigated. Our group has been involved in a research program aimed at targeting ruthenium-based lightactivated anticancer prodrugs to GLUT transporters by glucose conjugation. 17, 18 These photoactivated chemotherapeutic prodrugs are typically protected from binding to biomolecules in the dark by thioether ligands, which under visible light irradiation are photosubstituted by water, thereby activating the prodrug. 19−21 En route to functionalizing such complexes with glucose, it came out that all available synthetic routes toward a series of positional isomers of glucose were incompatible with the presence of thioether groups, which deactivate Pd/C catalysts used to deprotect benzyl protecting groups. For that reason, we developed and report here on a series of new synthetic routes toward all positional isomers of glucose that are compatible with the presence of sulfur-based ligands. 22 As traces of palladium also often interfere with the biological activity of pharmaceuticals, 23 these new routes do not make use of palladium catalysts. PEGylation of all positional isomers was also realized to vary the spacer between the thioether ligands and the glucose moiety. The coordination of the thioether−glucose ligands to known photoactive ruthenium(II) polypyridyl precursors afford 11 ruthenium−glucose conjugates ( Figure 1 ) as a demonstration that such molecules can be obtained on a synthetical useful scale. Recent publications describe the more photophysical and/or biological properties of these type of complexes. 17, 18 ■ RESULTS AND DISCUSSION Five hydroxyl groups are available for modification in D-glucose, of which the 1-O position is modified via chemical glycosylation. 24 Recently, Patra et al. have demonstrated that the spacer length exerts influence over the GLUT-mediated uptake of platinum complexes in cells; 14 however, there is currently no established understanding of this effect in cationic ruthenium(II) polypyridyl compounds. Therefore, oligoethylene glycol spacers [OCH 2 CH 2 ] n with varying lengths (n = 0−3) were introduced in glycoconjugates [1] (PF 6 ) 2 − [5] (PF 6 ) 2 ( Figure 1 ). The first complex in this series ( [1] (PF 6 ) 2 ) was synthesized starting from precursor 12 (Scheme 1). 25 This building block and NaSMe were used in a S N 2 reaction, ensuring the installment of the thioether group, affording 13. This ligand was then reacted with [Ru(tpy)(bpy)Cl]Cl, affording the orange (λ max = 450 nm) glycoconjugate [1] (PF 6 ) 2 . For complex [2](PF 6 ) 2 , a three-step one-pot synthesis starting from peracetylated glucose 14 (Scheme 2) was adapted from Valerio et al., 26 which afforded the trans-glucopyranoside as the only diastereoisomer. Treatment of this compound with sodium methoxide in methanol afforded fully deprotected 15 in a 55% overall yield. Subsequent reaction of this ligand with [Ru(tpy)(bpy)Cl]Cl then gave the orange complex [2](PF 6 ).
A different approach was employed for the installment of the ethylene glycol-based linkers (n = 1−3) for complexes [3] (PF 6 ) 2 − [5] (PF 6 ) 2 and [11] Cl 2 ( Figure 1 ). The disarmed Schmidt donor 20 (Scheme 3) was chosen due to its straightforward synthesis and robustness. The benzoyl protecting group in this building block was favored over the more common acetyl group, due to its lower reactivity. 27 Furthermore, this donor was chosen to reduce the possible formation of orthoesters, a common side reaction when using acetyl-bearing donors. 28 Commercially available 2-(methylthio)ethanol was used as an acceptor and condensed with donor 20 (Scheme 3), affording 21, which after de-O-benzoylation acquired deprotected 24. Compounds 25, 26 , and 28 were acquired in a similar fashion using acceptors 18, 19, and 1,3-bis(methylthio)propan-2-ol, respectively. The synthesis of the corresponding ruthenium complexes was found to be straightforward, by reacting excess ligand with the ruthenium species [Ru(tpy)(bpy)Cl]Cl or [Ru(bpy) 2 Cl 2 ]. Their purification, however, was found arduous due to the increased water solubility of these compounds. Common workup methods were not applicable, and the lability of these compounds on C-18 columns prevented reverse-phase chromatographic purification. The most reproducible approach was by purification over silica using a mixture of acetone, water, and aqueous KPF 6 , followed by Sephadex LH-20 size exclusion purification to remove excess salt and minor impurities. This method afforded the orange (λ max = 450 nm) ruthenium polypyridyl derivatives [3] (PF 6 ) 2 −[5](PF 6 ) 2 and [11] Cl 2 in moderate to good yields (28−66%). Park and co-workers have demonstrated that glucose bioprobes with a formal charge of +1 are taken up preferentially over neutral and negatively charged probes. 29 To allow future study of the effect on the overall charge for ruthenium(II) polypyridyl drugs on uptake and toxicity, a derivative of [Ru(tpy)(bpy)Cl]Cl bearing a negative charge on the spectator terpyridine ligand was also synthesized. Compound 31 (Scheme 4) was prepared starting from thione 29, 30 which was oxidized using in situ generated peracetic acid followed by hydrogenation using 10% palladium on carbon to reverse partial overoxidation to its N-oxide, affording ligand 30. A one-pot synthesis using (pcymene)ruthenium(II) chloride dimer 30 and bpy provided complex 31. Reaction of ligand 26 (Scheme 3) with this complex then gave the ruthenium complex [10](PF 6 ) 2 .
Demonstrations of the covalent modification of the 2-O position of D-glucose with an alkyl-based linker have been given by Dumas et al. and Patray and co-workers.
14,31 Both groups chose a similar approach starting from methyl 3,5,6-tri-Obenzyl-α/β-D-glucofuranoside followed by installment of the linker and subsequent deprotection of the protection groups using dihydrogen and palladium on carbon. Sulfur-based linkers, however, poisoned the palladium catalysts, which made removal of the benzyl protecting groups impossible following this approach. 22, 32 Other methods to remove benzyl groups, such as Birch reductions, have been reported to cleave thioethers. 33 Therefore, all described approaches for the functionalization of the O-2 position in D-glucose with a metal-binding moiety, including the glucofuranoside approach described by Schubiger or Lippard, or the approach via a benzylorthoacetate intermediate described by Miao et al. 34 were found unsuitable for thioether-containing compounds. We therefore devised a new protecting group strategy improving the 10-step, 5% yield procedure published by Lippard et al. 14 with tosylate 32 (Scheme 5) for the installment of the thioether moiety. This conversion proceeded smoothly, which is in contrast to the observation of Schubiger et al., who had to divert to the furanoside approach due to difficulties encountered during the installment of their iminodiacetic acid-based spacer. 31 With compound 36 in hand, a recently described method 37 using 37% hydrochloric acid in hexafluoroisopropanol (HFIP) was used to remove all four PMB groups simultaneously. After the reaction was quenched using Et 3 6 ). The synthesis of H46 was also attempted via an alternative approach using α-methyl glucose following a similar protecting group strategy. However, this proved to be unsuccessful due to the inertness of the anomeric methyl acetal toward acid.
Finally, the 6-O position of D-glucose was easily modified starting from dimethyl glucose 48 (Scheme 8), 43 which could be converted to 49 using a Williamson etherification with tosylate 32, followed by acid hydrolysis using dilute hydrochloric acid, affording methyl thioether H50 in 55% over two steps. C NMR were recorded in CD 3 OD and CDCl 3 with a chemical shift (δ) relative to the solvent peak on a Bruker AV 400 or AV 500 unit. High-resolution mass spectra were recorded by direct injection (2 μL of 2 μM solution in water/acetoneitrile; 50/50; v/v and 0.1% formic acid) in a mass spectrometer (Thermo Finnigan LTQ Orbitrap) equipped with an electrospray (250°C) with a resolution (R) = 60 000 at m/z 400 (mass range m/z = 150−2000) and dioctylphtalate (m/z = 391.28428) as a lock mass. The high-resolution mass spectrometer was calibrated prior to measurements with a calibration mixture (Thermo Finnigan). Melting point ranges were determined on a Stuart SMP30 unit. Elemental analysis for glycoconjugates [1] 25 (135 mg, 0.297 mmol) was dissolved in dry DMF (3 mL), and to this solution was added fresh NaSMe (23 mg, 0.33 mmol). The reaction was stirred overnight, after which it was diluted with EtOAc (25 mL), washed with water (2×) and aq NaHCO 3 (2×), and dried (Na 2 SO 4 ). Concentration in vacuo was followed by purification of the residue by silica column chromatography (10% MeOH in DCM), affording the title compound Methylthio-β-D-glucopyranoside (15) . α/β-D-Glucose pentaacetate (4.99 g, 12.4 mmol) was dissolved in anhydrous DCM (20 mL), and to this solution were added I 2 (4.84 g, 19.0 mmol) and Et 3 SiH (2.90 mL, 18.2 mmol). This mixture was allowed to stir for 10 min, after which it was diluted with DCM (100 mL) and washed with aqueous saturated Na 2 S 2 O 3 (1×) and Na 2 CO 3 (1×). Layers were separated, and the organic layer was dried (Na 2 SO 4 ) and concentrated in vacuo. The crude was coevaporated with toluene (3×) and redissolved in dry MeCN (20 mL), followed by the addition of thiourea (1.46 g, 19.2 mmol). The mixture was then heated for 30 min at 80°C, after which it was allowed to cool down to rt, followed by the addition of MeI (1.60 mL, 25.7 mmol) and Et 3 N (7.10 mL, 50.9 mmol). After an additional stirring for 10 min, the mixture was concentrated in vacuo, followed by purification of the residue over silica (0 to 50% Et 2 O in PE), yielding methyl 2,3,4,6-tetra-O-acetyl-1-thio-β-D-glucopyranoside as a yellow foam (2.71 g, 7.24 mmol). This compound was then dissolved in dry MeOH (70 mL) followed by the addition of a catalytic amount of NaOMe, which after stirring overnight was quenched upon the addition of Amberlite IR-120 H + . Filtration was followed by concentration in vacuo, yielding the title compound as a colorless oil (1.48 g, 7.04 mmol, 57% over four steps): R f (18) . To a flame-dried roundbottom flask was added freshly prepared NaSMe 44 (1.21 g, 15.5 mmol) under argon. Deoxygenated THF (50 mL) was added, followed by the addition of 2-chloroethoxy)ethanol (1.50 mL, 14.2 mmol). This solution was heated at 60°C for 6 h, after which it was allowed to cool to room temperature. The mixture was diluted with EtOAc (100 mL) and washed with aqueous NaHCO 3 (2×) and water (1×). The layers were separated, and the organic layer was dried (Na 2 SO 4 ) and concentrated in vacuo, affording a slightly yellowish oil (1.89 g, 13 ( 45 (370 mg, 0.364 mmol) and 2-(methylthio)ethanol (100 μL, 1.15 mmol) were coevaporated three times with anhydrous toluene, after which they were dissolved in anhydrous DCM (36 mL). Freshly activated 4 Å molecular sieves were added, and the mixture was allowed to stir for 15 min, after which a catalytic amount of TMSOTf (20.0 μL, 111 μmol) was added. After stirring for 4 h at room temperature, the reaction was quenched upon the addition of Et 3 N (100 μL, 0.714 mmol) and concentrated in vacuo followed by purification of the residue over silica (10% to 50% EtOAc in PE), affording the title compound The Journal of Organic Chemistry Article (C H arom ), 129.9 (C H arom ), 129.9 (C H arom ), 129.9 (C H arom ), 129.8 (C H arom ), 129.7 (C q arom ), 129.4 (C q arom ), 128.9 (C q arom ), 128.8 (C q arom ), 128.5 (C H arom ), 128.5 (C H arom ), 128.5 (C H arom ), 128.4 (C H arom ), 101.4 (C-1), 73.0 (C-3), 72.4 (C-5), 71.9 (C-2), 69. [2-(2-(Methylthio)ethoxy)]ethyl 2,3,4,6-tetra-O-benzoyl-β-D-glucopyranoside (22) . The general procedure described for 21 was followed, with 2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl trichloroacetimidate (6.00 g, 8.14 mmol) and 2-(2-(methylthio)ethoxy)ethanol (1.24 g, 9.10 mmol). Purification of the residue by silica column purification (0−25% EtOAc in PE) afforded the title compound as a clear oil (3. (2-Methylthio)ethyl-β-D-glucopyranoside (24). The protected glucoside 23 (240 mg, 0.410 mmol) was dissolved in MeOH (6 mL), after which a catalytic amount of NaOMe was added. The solution was allowed to stir for 16 h, after which Amberlite IR-120 H + was added, until a neutral pH. The resin was filtered off, and the mixture was concentrated in vacuo. Purification of the residue over silica (0 to [2-(2-(Methylthio)ethoxy)]-ethyl-β-D-glucopyranoside (25) . The procedure as described for 24 was followed, using protected glycoside 22 (560 mg, 0.780 mmol) and THF/MeOH (10 mL, 1:1). Purification of the crude over silica (0 to [1,3-Bis(methylthio)]-propyl-β-D-glucopyranoside (28) . The procedure as described for 22 was followed, using protected glycoside 27 (3.20 g, 4.38 mmol) and DCM/MeOH (50 mL, 1:50). Purification of the residue over silica (0 to 10% MeOH in DCM) afforded 28 as a white
The 46 (534 mg, 2.01 mmol) was suspended in acetic acid (6 mL). and to this mixture was added 30% H 2 O 2 (1 mL). The resulting purple mixture was heated at 70°C for 12 h and concentrated in vacuo. The crude was then redissolved in H 2 O, followed by the addition of 10% Pd/C (32 mg) and purged with H 2 (5 min). After stirring overnight at 40°C under a H 2 atmosphere, the reaction was filtered over Celite, concentrated, and purified over silica [Ru(S-tpy)(bpy)(Cl)] (31). Compound 30 (134 mg, 0.428 mmol) was dissolved in MeOH (10 mL), and to this solution was added 100 mg of washed Amberlite Na + . After the mixture stirred for 5 min at rt, the ionexchange resin was filtered off and the filtrate was concentrated in vacuo, affording a pinkish solid. This compound was then together with dichloro(p-cymene)ruthenium(II) dimer (130 mg, 0.213 mmol) redissolved in deoxygenated MeOH (5 mL) and heated to 60°C. A solution of bpy (69.0 mg, 0.440 mmol) in MeOH (2.3 mL) was then added dropwise over 10 min from which the color of the solution changed from purple to red. After stirring for 2 h under nitrogen, the solution was allowed to cool to rt, after which Et 2 O (20 mL) was added. 2-(2-(2-(Methylthio)ethoxy)ethoxy)ethyl 4-methylbenzenesulfonate (32) . Compound 19 (715 mg, 3.97 mmol) was dissolved in dry DCM (40 mL), and the mixture was cooled to 0°C. To this solution were added Et 3 N (850 ul, 6.09 mmol) and Ts-Cl (1.12 g, 5.87 mmol). The reaction was allowed to stir overnight, after which it was diluted with DCM (100 mL) and transferred to a separatory funnel. After washing with water (1×) and brine (1×), the layers were separated, and the organic layer was dried (Na 2 SO 4 ) and concentrated in vacuo. Purification of the residue by silica column chromatography (0 to 50% EtOAc in PE) afforded the title compound as a colorless oil ( 
3,4,6-Tri-O-(4-methoxybenzyl)-D-glucal (34).
To a cooled solution (0°C) of D-glucal in dry DMF (230 mL) was slowly added NaH (60% dispersion in mineral oil, 3.10 g, 77.5 mmol) followed by the addition of 4-methoxybenzyl chloride (10.1 mL, 74.5 mmol). After the mixture stirred overnight under a dinitrogen atmosphere, H 2 O (10 mL) was added and the mixture was allowed to stir for another 10 min. The mixture was further diluted with EtOAc (200 mL), transferred to a separatory funnel, and washed with water (3×) and brine (3×). The organic layer was dried over Na 2 SO 4 (35) . To a solution of protected glycoside 35 (821 mg, 1.62 mmol) in dry DCM (8 mL) under a dinitrogen atmosphere were added freshly activated 4 Å molecular sieves. After stirring for 15 min, the mixture was allowed to cool to 0°C and freshly prepared dimethyldioxirane in acetone (20 mL, 88 mM) was slowly added. The mixture was stirred for 3 h and allowed to reach rt, after which it was filtered over Celite and concentrated in vacuo. The crude was then, together with 4-methoxyl benzyl alcohol (335 mg, 2.42 mmol), redissolved in dry THF under a dinitrogen atmosphere, followed by the addition of freshly activated 4 Å molecular sieves. After stirring for 15 min, the mixture was cooled down to −78°C and a cooled solution (10°C ) of ZnCl 2 in dry THF (2.43 mL, 1 M) was added dropwise over 10 min. The mixture was allowed to stir overnight at rt, after which it was filtered over Celite, concentrated in vacuo, and purified by silica column chromatography ( 
4-Methoxybenzyl)-2-O-(2-[2-(2-(methylthio)ethoxy)ethoxy]-ethyl)-3,4,6-tetra-O-(4-methoxybenzyl)-β-D-glucopyranoside (36).
Glycoside 35 (333 mg, 0.504 mmol) was dissolved in dry DMF (5 mL) and cooled to 0°C. To this solution was added NaH (60% dispersion in mineral oil, 26 mg, 0.65 mmol) portionwise followed by the addition of tosylate 32 (185 mg, 0.554 mmol). After the mixture stirred for 6 h at rt under a dry atmosphere, MeOH was added (1 mL). The mixture was then diluted with EtOAc (50 mL), transferred to a separatory funnel, and washed with water (3×) and brine (3×). The organic layer was dried (Na 2 SO 4 ) and concentrated in vacuo. (38) . To a cooled solution of diacetone glucose (200 mg, 0.768 mmol) in dry DMF (8 mL) was added 60% NaH in mineral oil (80.0 mg, 2.00 mmol). After the mixture stirred for 5 min, tosylate 32 was added and the mixture was left overnight. After the reaction was quenched with MeOH (1 mL), Et 2 O (50 mL) was added and the reaction was transferred to a separatory funnel. After the mixture was washed with water (1×), aq NaHCO 3 (1×), and brine (1×), the layers were separated and the organic layer was dried (Na 2 SO 4 were added freshly activated 4 Å molecular sieves. The resulting mixture was allowed to stir for 10 min, after which Ag 2 CO 3 (6.00 g, 21.8 mmol) and I 2 (1.85 g, 7.30 mmol) were added. After the mixture stirred an additional 24 h under a dinitrogen atmosphere at rt in the dark, the reaction mixture was filtered over Celite, diluted with EtOAc (200 mL), and washed with 1 M Na 2 S 2 O 3 (3×), aq NaHCO 3 (3×), and brine (3×). The organic layer was dried (Na 2 SO 4 ) and concentrated in vacuo. Purification of the residue by silica column chromatography (20% EtOAc in DCM) afforded (4-methoxybenzyl)-2,3,4,6-tetra-O-acetyl-β-D-glucopyranoside (2.39 g), which was then redissolved in dry MeOH (70 mL) followed by the addition of a catalytic amount of NaOMe. The resulting mixture was allowed to stir for 4 h, after which Amberlite IR-120 H + was added until a neutral pH, filtered, and concentrated in vacuo, affording the title compound (42) . To a solution of 41 (309 mg, 1.03 mmol) in dry DMF (5 mL) were added 4-methoxybenzaldehyde dimethyl acetal (135 μL, 0.793 mmol) and p-TsOH·H 2 O (10 mg, 0.05 mmol). The resulting reaction mixture was heated at 60°C for 16 h, after which it was concentrated in vacuo. Saturated aqueous NaHCO 3 (50 mL) was added, and the mixture was further diluted with EtOAc (200 mL) and transferred to a separatory funnel. After the mixture was washed with aq NaHCO 3 (3×), water (3×) and brine (3×), the layers were separated, and the organic layer was dried (Na 2 SO 4 ) and concentrated in vacuo. (43) . To a cooled solution (0°C) of p-methoxy benzylidene protected 42 (377 mg, 0.900 mmol) in dry DMF (9 mL) was slowly added NaH (60% dispersion in mineral oil, 80.0 mg, 2.00 mmol) followed by the addition of 4-methoxybenzyl chloride (255 μL, 1.89 mmol). After stirring for 5 h under a dinitrogen atmosphere, the reaction was quenched upon the addition of MeOH (3 mL). The mixture was further diluted with Et 2 O (200 mL), transferred to a separatory funnel, and washed with water (1×), aq NaHCO 3 (1×),
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Article and brine (1×). The organic layer was dried over Na 2 SO 4 Fully protected glycoside 43 (400 mg, 0.610 mmol) was dissolved in DMF (12 mL), and to this solution were added freshly activated 4 Å molecular sieves and fresh NaCNBH 3 (385 mg, 6.13 mmol). After the mixture stirred for 15 min, the solution was cooled to 0°C, and a precooled solution (0°C) of trifluoroacetic acid (1.2 mL) in dry DMF (3 mL) on 4 Å molecular sieves was then added dropwise over 15 min. The reaction mixture was maintained at rt for 48 h and filtered over Celite, diluted with EtOAc (100 mL), and transferred to a separatory funnel. After washing with water (1×), aq NaHCO 3 (1×), and brine (1×), the organic layer was dried (Na 2 SO 4 ) and concentrated in vacuo. (45) . Compound 44 (300 mg, 0.454 mmol) was dissolved in dry DMF (5 mL), and the mixture was cooled to 0°C, after which 60% NaH in mineral oil (31 mg, 0.77 mmol) was added. This mixture was allowed to stir for 5 min, after which tosylate 32 (177 mg, 0.530 mmol) was added dropwise. The reaction was allowed to stir for 6 h, after which it was quenched upon the addition of MeOH (2 mL), diluted with Et 2 O (20 mL), and transferred to a separatory funnel. After washing with aq NaHCO 3 (1×), water (1×), and brine (1×), the layers were separated, and the organic layer was dried (Na 2 SO 4 ) and concentrated in vacuo. C-1), 84.3 (C-5), 82.0 (C-2), 78.7 (C-3) 6 ) 2 ). The title compound was synthesized analogous according to the procedure described for 8, 130.0, 129.9, 129.5, 129.3, 129.0, 129.0, 128.9, 126.2, 126.1 
